SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001571049-17-004464
Filing Date
2017-05-04
Accepted
2017-05-04 16:25:09
Documents
4
Group Members
DISCOVERY EQUITY PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 1) t1700300_sc13da.htm SC 13D/A 38992
2 EXHIBIT 1 t1700300_ex1.htm EX-1 25579
3 EXHIBIT 2 t1700300_ex2.htm EX-2 3653
4 EXHIBIT 3 t1700300_ex3.htm EX-3 5046
  Complete submission text file 0001571049-17-004464.txt   74763
Mailing Address 300 S WACKER DRIVE SUITE 600 CHICAGO IL 60606
Business Address 300 S WACKER DRIVE SUITE 600 CHICAGO IL 60606 (312) 265-9600
Discovery Group I, LLC (Filed by) CIK: 0001312548 (see all company filings)

IRS No.: 300075077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Subject) CIK: 0001488613 (see all company filings)

IRS No.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87922 | Film No.: 17814310
SIC: 8071 Services-Medical Laboratories